Beta-blocker therapy of heart failure: an update.

about

Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results.

P2860

Q38279998-ACB61BD7-3004-4FAF-B6DC-0234DDACD994

P2860

Beta-blocker therapy of heart failure: an update.

Item

http://www.wikidata.org/entity/Q36723828

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Beta-blocker therapy of heart failure: an update.

@ast

Beta-blocker therapy of heart failure: an update.

@en

type

Item

label

Beta-blocker therapy of heart failure: an update.

@ast

Beta-blocker therapy of heart failure: an update.

@en

prefLabel

Beta-blocker therapy of heart failure: an update.

@ast

Beta-blocker therapy of heart failure: an update.

@en

P1476

Beta-blocker therapy of heart failure: an update.

@en

P2093

Francesco Fracassi

http://www.w3.org/2001/XMLSchema#string

Livio Dei Cas

http://www.w3.org/2001/XMLSchema#string

Patrizia Milani

http://www.w3.org/2001/XMLSchema#string

Savina Nodari

http://www.w3.org/2001/XMLSchema#string

Tania Bordonali

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON)

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

Left ventricular assist device and drug therapy for the reversal of heart failure

Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

Mechanisms and models in heart failure: A combinatorial approach.

beta-adrenergic receptor blockade in chronic heart failure.

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

Effect of carvedilol on survival in severe chronic heart failure.

P304

289-298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.8.3.289

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marco Metra

P577

2007-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17266464

http://www.w3.org/2001/XMLSchema#string

Beta-blocker therapy of heart failure: an update.

about

P2860

P2860

Beta-blocker therapy of heart failure: an update.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698